Intracellular Amyloid-β Detection from Human Brain Sections Using a Microfluidic Immunoassay in Tandem with MALDI-MS.

Area of Science:

• Neuroscience
• Biochemistry
• Analytical Chemistry

Background:

• Alzheimer's disease (AD) affects over 30 million people globally, with limited understanding of its pathology hindering therapeutic development.
• Soluble amyloid-β (Aβ) oligomers are implicated as key neurotoxic species in AD, but intracellular Aβ in human brain cells remains poorly understood due to technological limitations.
• Investigating intracellular Aβ in specific human brain cell types is crucial for understanding AD's neurotoxic mechanisms.

Purpose of the Study:

• To develop and validate a microfluidic immunoassay for the in situ mass spectrometry analysis of intracellular Aβ species.
• To enable the assessment of intracellular Aβ in archived human brain tissue at the single-cell level.
• To provide a novel tool for gaining insights into the role of intracellular Aβ in Alzheimer's disease pathogenesis.

Main Methods:

• Utilized selective laser capture microdissection to isolate individual pyramidal cell bodies from archived human brain tissue.
• Developed a microfluidic platform for on-chip sample processing of isolated cells.
• Performed mass spectrometry for the characterization of intracellular Aβ species within the microfluidic system.

Main Results:

• Successfully demonstrated the detection of intracellular Aβ species using the developed microfluidic immunoassay.
• Achieved detection of intracellular Aβ from as few as 20 human brain cells, showcasing high sensitivity.
• Validated the feasibility of analyzing intracellular Aβ directly from archived human brain tissue.

Conclusions:

• The novel microfluidic immunoassay enables sensitive detection and characterization of intracellular Aβ species in human brain cells.
• This technology provides a powerful new approach for studying the role of intracellular Aβ in Alzheimer's disease.
• The findings pave the way for deeper understanding of AD pathophysiology and the development of targeted diagnostics and therapeutics.